Affiliation:
1. Hebei General Hospital affiliated to Hebei Medical University
2. Chinese PLA General Hospital
3. Beijing Tiantan Hospital, Capital Medical University
Abstract
Abstract
Migraine, highly prevalent among individuals under 50 years, is associated with oxidative stress. Telomere length shortening, closely linked to oxidative stress and aging, has not been comprehensively studied in its association with migraine and potential age-related influence. This cross-sectional study included data from 6,169 participants in the National Health and Nutrition Survey (NHANES) from 1999 to 2002. This encompassed information on peripheral blood leukocyte telomere length, severe headache or migraine, and potential confounders. Stratifying by age (20–50 years, > 50 years), we employed multivariable logistic regression and restricted cubic splines to investigate the relationship between telomere length and migraine. Further interaction test revealed age-influenced telomere length in relation to migraine. In participants aged 20–50 years, the odds ratio (OR) for migraine in the shortest telomere length group T1 (0.39–0.89) was 1.35 (95% confidence interval [95% CI]: 1.01, 1.79) compared to the longest group T3 (1.10–9.42), whereas in those aged > 50 years, the OR for the T1 group was 0.93 (95% CI: 0.60, 1.43). Additionally, telomere length and age interacted in the development of migraine (p for interaction: 0.010). Further analysis showed an L-shaped relationship between telomere length and migraine incidence in people aged 20–50 years, with an OR of 9.34 (95% CI: 1.56, 55.99) for migraine at telomere length < 1.02 T/S ratio. These findings revealed that age may influence the association between telomere length and migraine in U.S. adults. For Americans aged 20–50, telomere length demonstrated an L-shaped association with migraine, with an approximate inflection point at 1.02 T/S ratio.
Publisher
Research Square Platform LLC
Reference60 articles.
1. Migraine: epidemiology and systems of care;Ashina M;The Lancet,2021
2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Vos T;The Lancet,2020
3. Diagnosis and management of migraine in ten steps;Eigenbrodt AK;Nat Rev Neurol,2021
4. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Feigin VL;The Lancet Neurology,2019
5. Steiner, T. J., Stovner, L. J. & Vos, T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 17, 104 (2016).